Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cordonnier

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Presse Medicale (Paris, France : 1983)|March 14, 2001
[Heterogeneity of nephropathies in type 2 diabetes]D J Cordonnier, J F Cantin, N Pinel, et al.
Diabetes Care|November 30, 2006
Transforming growth factor-beta in human diabetic nephropathy: effects of ACE inhibitionRobyn G Langham, Darren J Kelly, Renae M Gow, et al.
Journal of the American Society of Nephrology : JASN|June 11, 1999
Expansion of cortical interstitium is limited by converting enzyme inhibition in type 2 diabetic patients with glomerulosclerosis. The Diabiopsies GroupD J Cordonnier, N Pinel, C Barro, et al.
Diabetologia|November 19, 2002
Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibitionR G Langham, D J Kelly, A J Cox, et al.
Nephrologie|January 1, 1996
[Ophthalmologic manifestations of dialysis. Retrospective study on 81 patients]T Hachache, M Guergour, B Gonzalvez, et al.
Inorganic Chemistry|December 16, 2016
Paramagnetic Resonance of Cobalt(II) Trispyrazolylmethanes and Counterion AssociationAmy R Marts, Joshua C Kaine, Robert R Baum, et al.
Journal of the American Society of Nephrology : JASN|August 27, 2005
Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitationsMarc A Pohl, Samuel Blumenthal, Daniel J Cordonnier, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Presse Medicale (Paris, France : 1983)|March 14, 2001
[Heterogeneity of nephropathies in type 2 diabetes]D J Cordonnier, J F Cantin, N Pinel, et al.
Diabetes Care|November 30, 2006
Transforming growth factor-beta in human diabetic nephropathy: effects of ACE inhibitionRobyn G Langham, Darren J Kelly, Renae M Gow, et al.
Journal of the American Society of Nephrology : JASN|June 11, 1999
Expansion of cortical interstitium is limited by converting enzyme inhibition in type 2 diabetic patients with glomerulosclerosis. The Diabiopsies GroupD J Cordonnier, N Pinel, C Barro, et al.
Diabetologia|November 19, 2002
Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibitionR G Langham, D J Kelly, A J Cox, et al.
Nephrologie|January 1, 1996
[Ophthalmologic manifestations of dialysis. Retrospective study on 81 patients]T Hachache, M Guergour, B Gonzalvez, et al.
Inorganic Chemistry|December 16, 2016
Paramagnetic Resonance of Cobalt(II) Trispyrazolylmethanes and Counterion AssociationAmy R Marts, Joshua C Kaine, Robert R Baum, et al.
Journal of the American Society of Nephrology : JASN|August 27, 2005
Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitationsMarc A Pohl, Samuel Blumenthal, Daniel J Cordonnier, et al.
Pageof 3